Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2011 1
2012 1
2013 1
2014 2
2015 1
2016 2
2017 1
2018 1
2019 2
2020 4
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
Faes C, Ilich A, Sotiaux A, Sparkenbaugh EM, Henderson MW, Buczek L, Beckman JD, Ellsworth P, Noubouossie DF, Bhoopat L, Piegore M, Renoux C, Bergmeier W, Park Y, Ataga KI, Cooley B, Wolberg AS, Key NS, Pawlinski R. Faes C, et al. Among authors: sparkenbaugh em. Blood. 2019 Jun 6;133(23):2529-2541. doi: 10.1182/blood.2019000424. Epub 2019 Apr 5. Blood. 2019. PMID: 30952675 Free PMC article.
Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.
Senchenkova EY, Ansari J, Becker F, Vital SA, Al-Yafeai Z, Sparkenbaugh EM, Pawlinski R, Stokes KY, Carroll JL, Dragoi AM, Qin CX, Ritchie RH, Sun H, Cuellar-Saenz HH, Rubinstein MR, Han YW, Orr AW, Perretti M, Granger DN, Gavins FNE. Senchenkova EY, et al. Among authors: sparkenbaugh em. Circulation. 2019 Jul 23;140(4):319-335. doi: 10.1161/CIRCULATIONAHA.118.039345. Epub 2019 Jun 3. Circulation. 2019. PMID: 31154815 Free PMC article.
Hypercoagulable state in sickle cell disease.
Faes C, Sparkenbaugh EM, Pawlinski R. Faes C, et al. Among authors: sparkenbaugh em. Clin Hemorheol Microcirc. 2018;68(2-3):301-318. doi: 10.3233/CH-189013. Clin Hemorheol Microcirc. 2018. PMID: 29614638
Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure.
Arnold K, Xu Y, Sparkenbaugh EM, Li M, Han X, Zhang X, Xia K, Piegore M, Zhang F, Zhang X, Henderson M, Pagadala V, Su G, Tan L, Park PW, Stravitz RT, Key NS, Linhardt RJ, Pawlinski R, Xu D, Liu J. Arnold K, et al. Among authors: sparkenbaugh em. Sci Transl Med. 2020 Mar 18;12(535):eaav8075. doi: 10.1126/scitranslmed.aav8075. Sci Transl Med. 2020. PMID: 32188725 Free PMC article.
Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.
Xu Y, Chandarajoti K, Zhang X, Pagadala V, Dou W, Hoppensteadt DM, Sparkenbaugh EM, Cooley B, Daily S, Key NS, Severynse-Stevens D, Fareed J, Linhardt RJ, Pawlinski R, Liu J. Xu Y, et al. Among authors: sparkenbaugh em. Sci Transl Med. 2017 Sep 6;9(406):eaan5954. doi: 10.1126/scitranslmed.aan5954. Sci Transl Med. 2017. PMID: 28878012 Free PMC article.
Homogeneous low-molecular-weight heparins with reversible anticoagulant activity.
Xu Y, Cai C, Chandarajoti K, Hsieh PH, Li L, Pham TQ, Sparkenbaugh EM, Sheng J, Key NS, Pawlinski R, Harris EN, Linhardt RJ, Liu J. Xu Y, et al. Among authors: sparkenbaugh em. Nat Chem Biol. 2014 Apr;10(4):248-50. doi: 10.1038/nchembio.1459. Epub 2014 Feb 23. Nat Chem Biol. 2014. PMID: 24561662 Free PMC article.
22 results